CoChat

Amino Acid Catabolism in Staphylococcus aureus and the Function of Carbon Catabolite Repression

Open access

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

Abstract

Staphylococcus aureus must rapidly adapt to a variety of carbon and nitrogen sources during invasion of a host. Within a staphylococcal abscess, preferred carbon sources such as glucose are limiting, suggesting that S. aureus survives through the catabolism of secondary carbon sources. S. aureus encodes pathways to catabolize multiple amino acids, including those that generate pyruvate, 2-oxoglutarate, and oxaloacetate. To assess amino acid catabolism, S. aureus JE2 and mutants were grown in complete defined medium containing 18 amino acids but lacking glucose (CDM). A mutation in the gudB gene, coding for glutamate dehydrogenase, which generates 2-oxoglutarate from glutamate, significantly reduced growth in CDM, suggesting that glutamate and those amino acids generating glutamate, particularly proline, serve as the major carbon source in this medium. Nuclear magnetic resonance (NMR) studies confirmed this supposition. Furthermore, a mutation in the ackA gene, coding for acetate kinase, also abrogated growth of JE2 in CDM, suggesting that ATP production from pyruvate-producing amino acids is also critical for growth. In addition, although a functional respiratory chain was absolutely required for growth, the oxygen consumption rate and intracellular ATP concentration were significantly lower during growth in CDM than during growth in glucose-containing media. Finally, transcriptional analyses demonstrated that expression levels of genes coding for the enzymes that synthesize glutamate from proline, arginine, and histidine are repressed by CcpA and carbon catabolite repression. These data show that pathways important for glutamate catabolism or ATP generation via Pta/AckA are important for growth in niches where glucose is not abundant, such as abscesses within skin and soft tissue infections. IMPORTANCE S. aureus is a significant cause of both morbidity and mortality worldwide. This bacterium causes infections in a wide variety of organ systems, the most common being skin and soft tissue. Within a staphylococcal abscess, levels of glucose, a preferred carbon source, are limited due to the host immune response. Therefore, S. aureus must utilize other available carbon sources such as amino acids or peptides to proliferate. Our results show that glutamate and amino acids that serve as substrates for glutamate synthesis, particularly proline, function as major carbon sources during growth, whereas other amino acids that generate pyruvate are important for ATP synthesis via substrate-level phosphorylation in the Pta-AckA pathway. Our data support a model whereby certain amino acid catabolic pathways, and acquisition of those particular amino acids, are crucial for growth in niches where glucose is not abundant.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/mbio.01434-16

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG 1 Growth of S. aureus JE2 in CDM. (A) Aerobic growth of JE2 in CDM displaying acetate and ammonia production. (B) Growth of JE2 and JE2 mqo1::NΣ strains in CDM lacking aspartate (CDM-D). (C) Growth of JE2 putA::NΣ, JE2 rocF::NΣ, JE2 rocA::NΣ, and JE2 hutU::NΣ strains in CDM lacking glutamate (CDM-E) in comparison to wild-type JE2. (D) Growth of JE2 rocF::NΣ, JE2 ccpA::tetL, and JE2 wild-type strains in CDM lacking proline (CDM-P) or arginine (CDM-R). Growth curve analyses whose results are shown in panels B to D were performed in three independent experiments; error bars represent the standard errors of the means (SEM). Data in panel A are representative of experiments performed three independent times.
FIG 1 Growth of S. aureus JE2 in CDM. (A) Aerobic growth of JE2 in CDM displaying acetate and ammonia production. (B) Growth of JE2 and JE2 mqo1::NΣ strains in CDM lacking aspartate (CDM-D). (C) Growth of JE2 putA::NΣ, JE2 rocF::NΣ, JE2 rocA::NΣ, and JE2 hutU::NΣ strains in CDM lacking glutamate (CDM-E) in comparison to wild-type JE2. (D) Growth of JE2 rocF::NΣ, JE2 ccpA::tetL, and JE2 wild-type strains in CDM lacking proline (CDM-P) or arginine (CDM-R). Growth curve analyses whose results are shown in panels B to D were performed in three independent experiments; error bars represent the standard errors of the means (SEM). Data in panel A are representative of experiments performed three independent times.CC BY · PubMed Central
FIG 2 Amino acid consumption of JE2 following growth in CDM. JE2 was grown aerobically in CDM, and amino acid concentrations (millimoles) were measured in the supernatant at 0, 4, 8, and 12 h of growth. The results are representative of two independent experiments.
FIG 2 Amino acid consumption of JE2 following growth in CDM. JE2 was grown aerobically in CDM, and amino acid concentrations (millimoles) were measured in the supernatant at 0, 4, 8, and 12 h of growth. The results are representative of two independent experiments.CC BY · PubMed Central
FIG 3 Amino acid catabolic pathways in S. aureus. Green arrows indicate those mutations that resulted in no significant growth defect compared to wild-type JE2 in CDM. Blue arrows indicate those mutations that resulted in intermediate growth defects compared to wild-type JE2 in CDM. Red arrows indicate mutations that completely inhibited growth of JE2 in CDM. Black arrows indicate that these pathways were not tested. Please see Fig. S1 for growth analyses.
FIG 3 Amino acid catabolic pathways in S. aureus. Green arrows indicate those mutations that resulted in no significant growth defect compared to wild-type JE2 in CDM. Blue arrows indicate those mutations that resulted in intermediate growth defects compared to wild-type JE2 in CDM. Red arrows indicate mutations that completely inhibited growth of JE2 in CDM. Black arrows indicate that these pathways were not tested. Please see Fig. S1 for growth analyses.CC BY · PubMed Central
FIG 4 Summary of cellular metabolite concentration changes resulting from supplementation of uniformly labeled amino acids in CDM. The bubble plot summarizes the metabolites derived from (U-13C4) aspartate (D), (U-13C5) glutamate (E), (U-13C5) proline (P), (U-13C6) histidine (H), (U-13C6) arginine (R), (U-13C4) threonine (T), (U-13C3) serine (S), (U-13C3) alanine (A), or (U-13C2) glycine (G) based on an analysis of triplicate 2D 1H-13C HSQC experiments. Due to the wide dynamic range of NMR intensities, the original NMR peak intensities were transformed by natural logarithm for the purpose of visualization. The relative sizes of the bubbles indicate the transformed values, where a larger diameter indicates a higher NMR peak intensity. The bubbles are colored using a red gradient to represent the original NMR peak intensity, where an increase in color intensity represents a corresponding increase in the original NMR peak intensity. Each level of increase in red intensity corresponds to a 10-fold increase in the NMR intensity. The bubbles with a purple outline identify metabolites observed during exponential phase. Bubbles with a green outline identify metabolites observed during stationary phase. Metabolite names are colored based on the assigned category as follows: orange, urea cycle; green, amino acid; black, glycolysis/gluconeogenesis; red, pentose phosphate pathway/nucleosides; blue, others.
FIG 4 Summary of cellular metabolite concentration changes resulting from supplementation of uniformly labeled amino acids in CDM. The bubble plot summarizes the metabolites derived from (U-13C4) aspartate (D), (U-13C5) glutamate (E), (U-13C5) proline (P), (U-13C6) histidine (H), (U-13C6) arginine (R), (U-13C4) threonine (T), (U-13C3) serine (S), (U-13C3) alanine (A), or (U-13C2) glycine (G) based on an analysis of triplicate 2D 1H-13C HSQC experiments. Due to the wide dynamic range of NMR intensities, the original NMR peak intensities were transformed by natural logarithm for the purpose of visualization. The relative sizes of the bubbles indicate the transformed values, where a larger diameter indicates a higher NMR peak intensity. The bubbles are colored using a red gradient to represent the original NMR peak intensity, where an increase in color intensity represents a corresponding increase in the original NMR peak intensity. Each level of increase in red intensity corresponds to a 10-fold increase in the NMR intensity. The bubbles with a purple outline identify metabolites observed during exponential phase. Bubbles with a green outline identify metabolites observed during stationary phase. Metabolite names are colored based on the assigned category as follows: orange, urea cycle; green, amino acid; black, glycolysis/gluconeogenesis; red, pentose phosphate pathway/nucleosides; blue, others.CC BY · PubMed Central
FIG 5 Metabolic indicators of JE2 growth in CDM, TSB, or CDMG. (A) Extracellular acetate detected following aerobic growth in CDM containing (U-13C4) aspartate (D), (U-13C5) glutamate (E), (U-13C5) proline (P), (U-13C6) histidine (H), (U-13C6) arginine (R), (U-13C4) threonine (T), (U-13C3) serine (S), (U-13C3) alanine (A), or (U-13C2) glycine (G). NMR peak intensity was assessed in early exponential (early), mid-exponential (middle), and late exponential (late) growth based on an analysis of the results of triplicate 2D 1H-13C HSQC experiments. Error bars represent standard errors of the means. (B) Intracellular concentration of citrate as measured in early and post-exponential phases of growth in CDM. (C and D) Relative rate of oxygen consumption (C) and ATP concentration (D) following growth of JE2 in CDM, CDMG, or TSB. Rates of JE2 grown in TSB were set at 100%. Samples for panels C and D were collected in mid-exponential phase. For panels B to D, significance was determined via an unpaired Students t test with Welch’s correction (*, P < 0.05; ***, P < 0.001; ****, P < 0.0001).
FIG 5 Metabolic indicators of JE2 growth in CDM, TSB, or CDMG. (A) Extracellular acetate detected following aerobic growth in CDM containing (U-13C4) aspartate (D), (U-13C5) glutamate (E), (U-13C5) proline (P), (U-13C6) histidine (H), (U-13C6) arginine (R), (U-13C4) threonine (T), (U-13C3) serine (S), (U-13C3) alanine (A), or (U-13C2) glycine (G). NMR peak intensity was assessed in early exponential (early), mid-exponential (middle), and late exponential (late) growth based on an analysis of the results of triplicate 2D 1H-13C HSQC experiments. Error bars represent standard errors of the means. (B) Intracellular concentration of citrate as measured in early and post-exponential phases of growth in CDM. (C and D) Relative rate of oxygen consumption (C) and ATP concentration (D) following growth of JE2 in CDM, CDMG, or TSB. Rates of JE2 grown in TSB were set at 100%. Samples for panels C and D were collected in mid-exponential phase. For panels B to D, significance was determined via an unpaired Students t test with Welch’s correction (*, P < 0.05; ***, P < 0.001; ****, P < 0.0001).CC BY · PubMed Central
FIG 6 Importance of aerobic and anaerobic respiration during growth in CDM. (A) Aerobic growth of JE2, JE2 qoxB::NΣ, and JE2 nrd2::NΣ strains in CDM. (B) Growth of JE2 in CDM following the addition of the ATP synthase inhibitor DCCD in early exponential phase. (C) Anaerobic growth (24 h) of JE2 in CDM containing either 3 mM sodium nitrate or 0.5% lactate (CDML). (D) Anaerobic growth (24 h) of JE2, JE2 gudB::NΣ, and JE2 ackA strains grown in CDM containing sodium nitrate (3 mM) and lactate (0.5%). Growth curve analyses were performed in three independent experiments; error bars represent the standard errors of the means (SEM).
FIG 6 Importance of aerobic and anaerobic respiration during growth in CDM. (A) Aerobic growth of JE2, JE2 qoxB::NΣ, and JE2 nrd2::NΣ strains in CDM. (B) Growth of JE2 in CDM following the addition of the ATP synthase inhibitor DCCD in early exponential phase. (C) Anaerobic growth (24 h) of JE2 in CDM containing either 3 mM sodium nitrate or 0.5% lactate (CDML). (D) Anaerobic growth (24 h) of JE2, JE2 gudB::NΣ, and JE2 ackA strains grown in CDM containing sodium nitrate (3 mM) and lactate (0.5%). Growth curve analyses were performed in three independent experiments; error bars represent the standard errors of the means (SEM).CC BY · PubMed Central
FIG 7 Amino acid consumption of JE2 following growth in CDMG. JE2 was grown aerobically in CDMG, and amino acid concentrations (mM) were measured from the supernatant at 0, 4, 8, and 12 h of growth. The results are representative of two independent experiments.
FIG 7 Amino acid consumption of JE2 following growth in CDMG. JE2 was grown aerobically in CDMG, and amino acid concentrations (mM) were measured from the supernatant at 0, 4, 8, and 12 h of growth. The results are representative of two independent experiments.CC BY · PubMed Central
FIG 8 Transcriptional analysis of putA, rocD, rocA, gudB, rocF, and hutU following growth in CDM and CDMG. Northern analysis was performed with RNA isolated from exponential (early) and post-exponential (late) phases of growth (both CDM and CDMG) from JE2 and JE2 ccpA::tetL strains. Equal loading of RNA was ensured via staining of the RNA gel with ethidium bromide and visualization of the 16S and 23S rRNA (data not shown).
FIG 8 Transcriptional analysis of putA, rocD, rocA, gudB, rocF, and hutU following growth in CDM and CDMG. Northern analysis was performed with RNA isolated from exponential (early) and post-exponential (late) phases of growth (both CDM and CDMG) from JE2 and JE2 ccpA::tetL strains. Equal loading of RNA was ensured via staining of the RNA gel with ethidium bromide and visualization of the 16S and 23S rRNA (data not shown).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 67 references

Cited by

Items 201–253 of 253

Metadata

Authors
Halsey, C. R., Lei, S., Wax, J. K., Lehman, M. K., Nuxoll, A. S., Steinke, L., Sadykov, M., Powers, R., & Fey, P. D.
Affiliations
  • University of Nebraska Medical Center (US)
  • University of Nebraska–Lincoln (US)
  • University of Nebraska at Kearney (US)
Corresponding author
  • Powers, Robert
  • Fey, Paul D.
Venue
mBio
Published
2017-03-08
Volume
8
Issue
1
ISSN
  • 2150-7511 (ISSN-L)
  • 2161-2129
OpenAlex
W2588283941
Cited by
233
References
67
Citations by year
2026: 14 · 2025: 41 · 2024: 40 · 2023: 18 · 2022: 27 · 2021: 31 · 2020: 17 · 2019: 23 · 2018: 16 · 2017: 6
FWCI
11.25
Type
journal article
Language
en
Open access
Licence
Locations
  • mBio (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Lincoln (University of Nebraska) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
HHS | NIH | National Institute of Allergy and Infectious Diseases (P01 AIAI083211)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Microbial metabolism and enzyme function
Keywords
Staphylococcus aureus, amino acid catabolism, catabolite repression, California Consumer Privacy Act, glutamate dehydrogenase, acetate kinase, ackA, proline, glutamate, pyruvate, alpha-ketoglutarate, oxaloacetate, ATP production, skin and soft tissue infections, abscess, glucose limitation
MeSH terms
Abscess, Adenosine Triphosphate, Amino Acids, Bacterial Proteins, Carbon, Glucose, Glutamate Dehydrogenase, Mutation, Staphylococcus aureus, Glutamic Acid, Gene Expression Profiling, Catabolite Repression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.